These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18540977)

  • 1. Expression of leukaemia inhibitory factor in epithelial ovarian carcinoma: correlation with clinical characteristics.
    Ye F; Hu Y; Lu W; Zhou C; Xie X
    Histopathology; 2008 Aug; 53(2):224-8. PubMed ID: 18540977
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphometrical and immunohistochemical criteria of prognosis in patients with serous and mucinous ovarian carcinoma].
    Kolosov AE; Novichkov EV
    Arkh Patol; 2003; 65(5):29-32. PubMed ID: 14664145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
    Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TTF-1 expression in primary ovarian epithelial neoplasia.
    Graham AD; Williams AR; Salter DM
    Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
    Feng QL; Shi HR; Qiao LJ; Zhao J
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
    Yang YQ; Li JC
    Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
    Cao LQ; Chen XM; Li X
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of detecting telomerase activity in ascites cells from patients with ovarian carcinoma].
    Jin S; Zhang W; Wang H; Liu Y; Gao F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Dec; 21(6):455-9. PubMed ID: 12567493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
    Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?
    Benito V; Lubrano A; Arencibia O; Medina N; Álvarez Eva E; Andújar M; Falcón Juan M; Falcón O
    Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):188-92. PubMed ID: 20728981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis.
    Määttä M; Bützow R; Luostarinen J; Petäjäniemi N; Pihlajaniemi T; Salo S; Miyazaki K; Autio-Harmainen H; Virtanen I
    J Histochem Cytochem; 2005 Oct; 53(10):1293-300. PubMed ID: 15923364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
    Yuan ZF; Shi HR; Sun HM; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
    [No Abstract]   [Full Text] [Related]  

  • 14. TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
    El-Balat A; Schmeil I; Karn T; Becker S; Sänger N; Holtrich U; Arsenic R
    Pathol Oncol Res; 2018 Apr; 24(2):277-282. PubMed ID: 28470574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian cancer prognosis and expression of receptors to sex hormones and proliferative activity of tumor cells].
    Novichkov EV; Votintsev AA
    Arkh Patol; 2006; 68(2):10-3. PubMed ID: 16752501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of macrophage migration inhibitory factor, p53 and CD34 in ovarian carcinoma].
    He CZ; Xia XA; Wu YY; Pu H; Lü B; Mao YR; Zhang ZY; Gao WH
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):261-2. PubMed ID: 17706119
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on expression of proliferating cell nuclear antigen (PCNA) in ovarian cancer].
    Terauchi F; Ueno R; Tanabe K; Ogura H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Nov; 48(11):1058-62. PubMed ID: 8940694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.
    Imai A; Ohno T; Ohsuye K; Tamaya T
    Ann Clin Biochem; 1994 Nov; 31 ( Pt 6)():550-5. PubMed ID: 7880073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of IL10 in epithelial ovarian tumor tissue and cell line and its clinical significance].
    Zhou JW; Qian YS; Xie X; Lu WG; Chen HZ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1911-3. PubMed ID: 15631806
    [No Abstract]   [Full Text] [Related]  

  • 20. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.